D R Johns Lab Pharma Private Limited

Pharma company manufacturing and marketing various products for clients.

2010 | New Delhi, Delhi (India) | Active
Last Updated: July 07, 2024

D R Johns Lab Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.77 Cr
  • Satisfied Charges ₹ 1.11 Cr
  • Revenue Growth 11.24%
  • Profit Growth 119.31%
  • Ebitda -12.15%
  • Net Worth 11.01%
  • Total Assets 11.54%

About D R Johns Lab Pharma

D R Johns Lab Pharma Private Limited (DRJLPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 June 2010 and has a history of 14 years and eight months. Its registered office is in New Delhi, Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹1.77 Cr. The company has closed loans amounting to ₹1.11 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at D R Johns Lab Pharma Private Limited India is Ramnish Sharma as CEO. Anita Sharma and Shyam Chandra serve as directors at the Company.

Company Details

  • Location

    New Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232DL2010PTC203412

  • Company No.

    203412

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    01 Jun 2010

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does D R Johns Lab Pharma Private Limited offer?

D R Johns Lab Pharma Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Dentist Tools, Equipment & Supplies, Oral Care Kit, Nutraceuticals & Dietary Supplements, Mineral Supplement, Industrial Mixers & Homogenizers, Continuous Mixer, Dietary Supplements, Hand Sanitizers & Personal Hygiene.

Who are the key members and board of directors at D R Johns Lab Pharma?

Executive Team (1)

Name Designation Appointment Date Status
Ramnish Sharma Country flag representing In CEO 26-May-2014 Current

Board Members (2)

Name Designation Appointment Date Status
Anita Sharma Country flag representing In Director 01-Jun-2010 Current
Shyam Chandra Country flag representing In Director 01-Jul-2017 Current

Financial Performance of D R Johns Lab Pharma.

D R Johns Lab Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.24% increase. The company also saw a substantial improvement in profitability, with a 119.31% increase in profit. The company's net worth Soared by an impressive increase of 11.01%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
11.24%
Revenue from Operations
11.03%
Total Assets
11.54%
Profit or Loss
119.31%
Net Worth
11.01%
EBITDA
-12.15%

What is the Ownership and Shareholding Structure of D R Johns Lab Pharma?

In 2023, D R Johns Lab Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹17.67 M

Satisfied Charges

₹11.05 M

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 0.77 Cr
  • Others : 0.51 Cr
  • Axis Bank Limited : 0.49 Cr

Latest Charge Details

Date Lender Amount Status
16 Feb 2023 Hdfc Bank Limited ₹1.84 M Open
10 Aug 2022 Hdfc Bank Limited ₹4.09 M Open
17 May 2022 Hdfc Bank Limited ₹1.77 M Open
28 Sep 2020 Others ₹1.78 M Open
30 Jan 2020 Axis Bank Limited ₹4.91 M Open

How Many Employees Work at D R Johns Lab Pharma?

Unlock and access historical data on people associated with D R Johns Lab Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of D R Johns Lab Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D R Johns Lab Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on D R Johns Lab Pharma

Recent activity within the organization

  • Annual General Meeting

    D R Johns Lab Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    D R Johns Lab Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

    31 Mar 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.84 M with Charge ID 100710340 was registered on 16 Feb 2023.

    16 Feb 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 4.09 M with Charge ID 100658842 was registered on 10 Aug 2022.

    10 Aug 2022

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.77 M with Charge ID 100593812 was registered on 17 May 2022.

    17 May 2022

  • Charges

    A charge registered on 19 Mar 2018 via Charge ID 100171631 with Others was fully satisfied on 30 Sep 2021.

    30 Sep 2021

Frequently asked questions

  • D R Johns Lab Pharma Private Limited was incorporated on 01 Jun 2010.

  • The authorized share capital of D R Johns Lab Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with D R Johns Lab Pharma Private Limited.

    • Anita Sharma
    • Ramnish Kumar Sharma
    • Shyam Chandra
  • As per Ministry of Corporate Affairs (Mca), the registered address of D R Johns Lab Pharma Private Limited is 212 Ch. Dilip Singh Bhawan Shahpur Jat, New Delhi, India, 110049.

  • The corporate identification number (CIN) of D R Johns Lab Pharma Private Limited is U24232DL2010PTC203412 and the company number is 203412 as per Ministry of Corporate Affairs (MCA).

  • The Official website of D R Johns Lab Pharma Private Limited is https://www.drjohnslab.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for D R Johns Lab Pharma Private Limited has risen by 11.24%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of D R Johns Lab Pharma Private Limited has experienced an upsurge of 11.01%.

  • As per the financial statements for fiscal Year 2023, The total open charges for D R Johns Lab Pharma Private Limited amount to ₹ 1.77 Cr.

  • The most recent Balance Sheet for D R Johns Lab Pharma Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development